New York, NY -- (SBWIRE) -- 01/03/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Genco Shipping & Trading Limited (NYSE:GNK), Synergy Pharmaceuticals Inc (NASDAQ:SGYP), BioCryst Pharmaceuticals, Inc (NASDAQ:BCRX), Ur-Energy Inc. (USA) (NYSEMKT:URG)
Genco Shipping & Trading Limited (NYSE:GNK) showed a volume of 1.27million shares by the end of last trade whereas the average volume of the stock remained 2.06 million shares. The stock opened the session at $2.47 but then moved to $2.56. At that price, the stock showed a positive performance of 2.40%. Genco Shipping & Trading Limited (GS&T) transports iron ore, coal, grain, steel products and other drybulk cargoes along worldwide shipping routes through the ownership and operation of drybulk carrier vessels. As of December 31, 2012, GS&T’s fleet consisted of 53 drybulk carriers, including nine capesize, eight panamax, 17 supramax, six handymax and 13 handysize drybulk carriers, with an aggregate carrying capacity of approximately 3,810,000 deadweight tonnages.
Will GNK Continue To Move Higher? Find Out Here
Synergy Pharmaceuticals Inc (NASDAQ:SGYP) opened the session at $5.77 and closed the session at $5.63. Traded with volume of 1.26 million shares in the prior session and the average volume of the stock remained 518,847.00 shares. Synergy Pharmaceuticals, Inc. is a biopharmaceutical company focused primarily on the development of drugs to treat gastrointestinal (GI), disorders and diseases. The Company’s lead product candidate is plecanatide, a guanylyl cyclase C (GC-C), receptor agonist, to treat GI disorders, primarily chronic constipation (CC), and constipation-predominant-irritable bowel syndrome (IBS-C).
Is SGYP a Solid Investment at These Levels? Read This Report For Details
BioCryst Pharmaceuticals, Inc (NASDAQ:BCRX) opened the session at $7.55 and closed the session at $7.90. The stock showed a positive performance of 3.95% in previous trading session. The beta of the stock remained 3.03. BioCryst Pharmaceuticals, Inc. (BioCryst) is a biotechnology company. BioCryst designs, optimizes and develops drugs that block enzymes involved in the pathogenesis of diseases. The Company focuses on therapeutic areas. Peramivir is its product, which is a neuraminidase inhibitor for the treatment of patients with influenza. The Company has two purine nucleoside phosphorylase (PNP) inhibitors that are in development,
Why Should Investors Buy BCRX After The Recent Gain? Just Go Here and Find Out
Ur-Energy Inc. (USA) (NYSEMKT:URG) the stock advanced 0.72% and finished the session at $1.39. Traded with volume of 1.23 million shares in the prior session and the average volume of the stock remained 784,829.00 shares. The beta of the stock remained 2.05. Ur-Energy Inc. (Ur-Energy) is an exploration-stage junior mining company. The Company is engaged in the identification, acquisition, evaluation, exploration and development of uranium mineral properties located primarily in Canada and the United States with additional exploration interests in Canada. The Company's Canadian properties include Screech Lake and Gravel Hill,
Will URG Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)